Mendelian randomisation estimates of the PCSK9 drug score on circulating metabolic traits.
收藏NIAID Data Ecosystem2026-03-13 收录
数据链接：
官方服务：
资源简介：
(XLSX)
应用场景：
创建时间：
2022-02-25
相关数据集
Supplementary Material for: Drug Target Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Atrial Fibrillation
Introduction: Atrial fibrillation (AF) is a prevalent cardiac arrhythmia with significant clinical implications. The potential influence of lipid-lowering therapies, specifically PCSK9 inhibitors (PCS
Figshare2024-03-26 更新60
Additional file 1 of Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Additional file 1: Table S1. Information of eQTL and GWAS summary data. Table S2. SMR association between expression of gene HMGCR, PCSK9, or NPC1L1 and inflammatory bowel diseases. Table S3. IVW-MR a
NIAID Data Ecosystem50
DataSheet1_Glucagon-like peptide-1 receptor agonists and the risk of erectile dysfunction: a drug target Mendelian randomization study.docx
BackgroundGlucagon-like peptide-1 receptor agonists (GLP-1RAs) have been widely used for type 2 diabetes (T2D) and weight management. However, the causal relationship of GLP-1RAs with erectile dysfunc
NIAID Data Ecosystem10
Genetically proxied IL4/IL-13 inhibition was not associate with the risk of cutaneous T-cell lymphoma: Drug-Target Mendelian Randomization Analyses
This study aimed to delve into the potential causal nexus between dupilumab and cutaneous T-cell lymphomas (CTCL), leveraging publicly accessible, anonymized summary data sourced from prior genome-wid
Mendeley Data50
Additional file 1 of Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
Additional file 1: Table S1. STROBE-MR checklist. Table S2. Phenotype descriptions and distributions. Table S3. Lipid-lowering drug classes, substances, and target genes. Table S4. Genetic variants th
Figshare2024-08-18 更新20
